BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lu RC, She B, Gao WT, Ji YH, Xu DD, Wang QS, Wang SB. Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects. World J Gastroenterol 2019; 25(32): 4682-4695 [PMID: 31528094 DOI: 10.3748/wjg.v25.i32.4682]
URL: https://www.wjgnet.com/2307-8960/full/v25/i32/4682.htm
Number Citing Articles
1
Reyhaneh Manafi-Farid, Bahar Ataeinia, Shaghayegh Ranjbar, Zahra Jamshidi Araghi, Mohammad Mobin Moradi, Christian Pirich, Mohsen Beheshti. ImmunoPET: Antibody-Based PET Imaging in Solid TumorsFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.916693
2
Matej Murgaš, Paul Michenthaler, Murray Bruce Reed, Gregor Gryglewski, Rupert Lanzenberger. Correlation of receptor density and mRNA expression patterns in the human cerebral cortexNeuroImage 2022; 256: 119214 doi: 10.1016/j.neuroimage.2022.119214
3
Benjamin Buchard, Camille Teilhet, Natali Abeywickrama Samarakoon, Sylvie Massoulier, Juliette Joubert-Zakeyh, Corinne Blouin, Christelle Reynes, Robert Sabatier, Anne-Sophie Biesse-Martin, Marie-Paule Vasson, Armando Abergel, Aicha Demidem. Two Metabolomics Phenotypes of Human Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease According to Fibrosis SeverityMetabolites 2021; 11(1): 54 doi: 10.3390/metabo11010054
4
Recep Erçin SÖNMEZ, Florent L. BESSON, Jerome GHİDAGLIA, Maïté LEWIN, Lea GOMEZ, Chady SALLOUM, Gabriella PITTAU, Oriana CIACIO, Marc Antoine ALLARD, Daniel CHERQUI, René ADAM, Antonio SA CUNHA, Daniel AZOULAY, Eric VİBERT, Nicolas GOLSE. Towards refining the utility of dual (18F-FDG / 18F-Choline) PET/CT for the management of hepatocellular carcinoma: a tertiary center studyThe Quarterly Journal of Nuclear Medicine and Molecular Imaging 2023; 67(3) doi: 10.23736/S1824-4785.22.03485-9
5
Gianvito Candita, Sara Rossi, Karolina Cwiklinska, Salvatore Claudio Fanni, Dania Cioni, Riccardo Lencioni, Emanuele Neri. Imaging Diagnosis of Hepatocellular Carcinoma: A State-of-the-Art ReviewDiagnostics 2023; 13(4): 625 doi: 10.3390/diagnostics13040625
6
Kazuhiro Katayama. Treatment strategy for and malignant potential of hepatocellular carcinoma within the Milan criteriaKanzo 2021; 62(8): 439 doi: 10.2957/kanzo.62.439
7
Abu Bakar Hafeez Bhatti, Wajih Naqvi, Nusrat Yar Khan, Haseeb Haider Zia, Faisal Saud Dar, Zahid Amin Khan, Atif Rana. Living donor liver transplantation for advanced hepatocellular carcinoma including macrovascular invasionJournal of Cancer Research and Clinical Oncology 2022; 148(1): 245 doi: 10.1007/s00432-021-03665-9
8
Keith Wan Hang Chiu, Kel Vin Tan, Xinxiang Yang, Xiaoqiang Zhu, Jingjing Shi, Chi-Leung Chiang, Lawrence Chan, Yuan Hui, Pek-Lan Khong, Kwan Man, Jason Wing Hon Wong. Prognostic PET [11C]-acetate uptake is associated with hypoxia gene expression in patients with late-stage hepatocellular carcinoma – a bench to bed studyCancer Imaging 2024; 24(1) doi: 10.1186/s40644-024-00685-9
9
Shaobo Wang, Boqiao Li, Pengfei Li, Ran Xie, Quanshi Wang, Hong Shi, Jianfeng He. Feasibility of perfusion and early-uptake 18F-FDG PET/CT in primary hepatocellular carcinoma: a dual-input dual-compartment uptake modelJapanese Journal of Radiology 2021; 39(11): 1086 doi: 10.1007/s11604-021-01140-6
10
Yan Hu, Guobing Liu, Haojun Yu, Jianying Gu, Hongcheng Shi. Diagnostic performance of total-body 18F-FDG PET/CT with fast 2-min acquisition for liver tumours: comparison with conventional PET/CTEuropean Journal of Nuclear Medicine and Molecular Imaging 2022; 49(10): 3538 doi: 10.1007/s00259-022-05772-2
11
Shubhangi Agarwal, Jeremy Gordon, Robert A. Bok, Cornelius von Morze, Daniel B. Vigneron, John Kurhanewicz, Michael A. Ohliger. Distinguishing metabolic signals of liver tumors from surrounding liver cells using hyperpolarized 13C MRI and gadoxetateMagnetic Resonance in Medicine 2024; 91(5): 2114 doi: 10.1002/mrm.29918
12
Jordan D. LeGout, Ryan E. Bailey, Candice W. Bolan, Andrew W. Bowman, Frank Chen, Joseph G. Cernigliaro, Lauren F. Alexander. Multimodality Imaging of Abdominopelvic Tumors with Venous InvasionRadioGraphics 2020; 40(7): 2098 doi: 10.1148/rg.2020200047
13
Calvin Sidhu, Lokesh Yagnik. Recurrent hepatocellular carcinoma presenting as thoracic lymphadenopathyRespirology Case Reports 2021; 9(7) doi: 10.1002/rcr2.792
14
Yi Dong, Wen-Ping Wang, Won Jae Lee, Maria Franca Meloni, Dirk-Andre Clevert, Maria Cristina Chammas, Andrea Tannapfel, Antonella Forgione, Fabio Piscaglia, Christoph Frank Dietrich. Hepatocellular carcinoma in the non-cirrhotic liverClinical Hemorheology and Microcirculation 2022; 80(4): 423 doi: 10.3233/CH-211309
15
Stanley Fayn, A. Paden King, Nicholas T. Gutsche, Zhijian Duan, Jesse Buffington, Colleen P. Olkowski, Ying Fu, Jessica Hong, Deepak Sail, Kwamena E. Baidoo, Rolf E. Swenson, Ross W. Cheloha, Mitchell Ho, Peter L. Choyke, Freddy E. Escorcia. Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3–Expressing Liver Cancer by Immuno-PETJournal of Nuclear Medicine 2023; 64(7): 1017 doi: 10.2967/jnumed.122.265171
16
N. E. Nyakale, C. Aldous, A. A. Gutta, X. Khuzwayo, L. Harry, M. M. Sathekge. Emerging theragnostic radionuclide applications for hepatocellular carcinomaFrontiers in Nuclear Medicine 2023; 3 doi: 10.3389/fnume.2023.1210982
17
Tao Wang, Boqiao Li, Hong Shi, Pengfei Li, Yinglei Deng, Siyu Wang, Qiao Luo, Dongdong Xv, Jianfeng He, Shaobo Wang. Short-term PET-derived kinetic estimation for the diagnosis of hepatocellular carcinoma: a combination of the maximum-slope method and dual-input three-compartment modelInsights into Imaging 2023; 14(1) doi: 10.1186/s13244-023-01442-5
18
Sofi Dhanaraj, Tahir Shah, Joanne O'Rourke, Shishir Shetty. Hepatocellular carcinoma: update on treatment guidelinesGastrointestinal Nursing 2020; 18(Sup10): S18 doi: 10.12968/gasn.2020.18.Sup10.S18
19
Kiran Arshad, Sheikh Danial Hanan, Muhammad Numair Younis, Rimsha Badar, Minahil Imran, Nefal Numair, Abubakar Imran. Detection of Primary Hepatocellular Carcinoma on18F-Fluorodeoxyglucose Positron Emission Tomography-computed TomographyEuroasian journal of hepato-gastroenterology 2023; 13(2): 66 doi: 10.5005/jp-journals-10018-1409
20
Ender Anılır, Alihan Oral, Fatih Turker, Tolga Şahin, Feyza Sönmez Topçu, Yıldıray Yuzer, Yaman Tokat. Predictive Value of Preoperative 18 Fludeoxyglucose Positron Emission Tomography–Computed Tomography for Survival in Liver Transplantation Due to Hepatocellular CancerTransplantation Proceedings 2024; 56(1): 111 doi: 10.1016/j.transproceed.2023.12.007
21
Yitong Li, Ruihang Zhang, Zhen Xu, Zhicheng Wang. Advances in Nanoliposomes for the Diagnosis and Treatment of Liver CancerInternational Journal of Nanomedicine 2022; : 909 doi: 10.2147/IJN.S349426
22
David Brasse, Hélène Burckel, Patrice Marchand, Marc Rousseau, Ali Ouadi, Marie Vanstalle, Christian Finck, Patrice Laquerriere, Frédéric Boisson. Comparison of the [18F]-FDG and [18F]-FLT PET Tracers in the Evaluation of the Preclinical Proton Therapy Response in Hepatocellular CarcinomaMolecular Imaging and Biology 2021; 23(5): 724 doi: 10.1007/s11307-021-01602-3
23
Mai M. K. Barakat, Ethar M. Badran, Yasmine Emad Aldin Hassan Allam, Zenat Ahmed Alsabbagh, Ahmed S. Abdelrahman. The role of triphasic CT imaging and 18F FDG PET CT on detection of extrahepatic metastases and proper staging of HCC: a comparative studyEgyptian Journal of Radiology and Nuclear Medicine 2022; 53(1) doi: 10.1186/s43055-022-00808-x
24
Yunxi Liu, Yue Chen, Weidong Fei, Caihong Zheng, Yongquan Zheng, Miao Tang, Ying Qian, Xiao Zhang, Mengdan Zhao, Meng Zhang, Fengmei Wang. Silica-Based Nanoframeworks Involved Hepatocellular Carcinoma TheranosticFrontiers in Bioengineering and Biotechnology 2021; 9 doi: 10.3389/fbioe.2021.733792
25
Bingqian Zhang, Mingyue Zou, Zengxin Lu, Haijia Mao, Ya’nan Huang, Fang Liu, Zhenhua Zhao. Imaging Manifestations of Intrahepatic Reactive Lymphoid Hyperplasia: A Case Report and Literature ReviewFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.694934
26
Jianfeng He, Tao Wang, Yongjin Li, Yinglei Deng, Shaobo Wang. Dynamic chaotic gravitational search algorithm-based kinetic parameter estimation of hepatocellular carcinoma on 18F-FDG PET/CTBMC Medical Imaging 2022; 22(1) doi: 10.1186/s12880-022-00742-4
27
Angelo Castello, Egesta Lopci. Imaging HCC treated with radioembolization: review of the literature and clinical examples of choline PET utilityClinical and Translational Imaging 2020; 8(5): 377 doi: 10.1007/s40336-020-00384-y
28
Kanhaiyalal Agrawal, Sayak Choudhury, Arvind Suresh, Archi Agrawal, Gopinath Gnanasegaran. Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology2021; : 187 doi: 10.1007/978-3-030-68858-5_14
29
Lina Garcia Cañamaque, Felipe S. Furtado, Caroline Ann Field Galán, Grace Lo, Mercedes Mitjavilla Casanovas, Yolanda Quijano Collazo, Cristina Ferrone, Jeffrey W. Clark, Onofrio Antonio Catalano. Clinical PET/MRI2023; : 267 doi: 10.1016/B978-0-323-88537-9.00014-3
30
Matteo Renzulli, Nicolò Brandi, Giulia Argalia, Stefano Brocchi, Andrea Farolfi, Stefano Fanti, Rita Golfieri. Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesionsLa radiologia medica 2022; 127(2): 129 doi: 10.1007/s11547-022-01449-w
31
Xiaowei Fan, Xiaoxiao Wang, Zijing Li, Yesen Li. 68Ga-Labeled TMTP1 Derivatives with Moderate Hydrophilicity for Positron Emission Tomography of Hepatocellular Carcinoma in High ContrastJournal of Medicinal Chemistry 2023; 66(10): 6756 doi: 10.1021/acs.jmedchem.3c00111
32
Akhil Pulumati, Anika Pulumati, Bilikere S. Dwarakanath, Amit Verma, Rao V. L. Papineni. Technological advancements in cancer diagnostics: Improvements and limitationsCancer Reports 2023; 6(2) doi: 10.1002/cnr2.1764
33
2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III RecommendationsJournal of Clinical and Experimental Hepatology 2024; 14(1): 101269 doi: 10.1016/j.jceh.2023.08.005
34
Madunil Anuk Niriella, Uditha Dassanayake, H Janaka de Silva. Mistakes in managing hepatocellular carcinoma and how to avoid them: a narrative reviewExpert Review of Gastroenterology & Hepatology 2023; 17(9): 913 doi: 10.1080/17474124.2023.2255515
35
Vanessa Murad, E. Edmund Kim, Jin-Chul Paeng, Hyung-Jun Im, Gi-Jeong Cheon. Atlas and Anatomy of PET/MRI, PET/CT and SPECT/CT2022; : 1 doi: 10.1007/978-3-030-92349-5_1
36
Shen-Yen Lin, Chien-Ming Chen, Bing-Shen Huang, Ying-Chieh Lai, Kuang-Tse Pan, Shi-Ming Lin, Sung-Yu Chu, Jeng-Hwei Tseng, Pierpaolo Alongi. A preliminary study of hepatocellular carcinoma post proton beam therapy using MRI as an early prediction of treatment effectivenessPLOS ONE 2021; 16(3): e0249003 doi: 10.1371/journal.pone.0249003
37
Yanjie Wang, Yuan Sun, Xueyuan Zeng, Rongqiang Zhuang, Jinxiong Huang, Xianzhong Zhang, Zhide Guo, Yesen Li. 68Ga-Labeled TMTP1 Modified with d-Amino Acid for Positron Emission Tomography Diagnosis of Highly Metastatic Hepatocellular CarcinomaJournal of Medicinal Chemistry 2024; 67(3): 2165 doi: 10.1021/acs.jmedchem.3c02090
38
Vanessa Murad, E. Edmund Kim, Jin-Chul Paeng, Camilo Barragan, Gi-Jeong Cheon. Atlas and Anatomy of PET/MRI, PET/CT and SPECT/CT2022; : 53 doi: 10.1007/978-3-030-92349-5_2
39
Yannick Kuhl, Stephan Naunheim, David Schug, Volkmar Schulz, Florian Mueller. Angular Irradiation Methods for DOI Calibration of Light-Sharing Detectors—A Perspective for PET In-System CalibrationIEEE Transactions on Radiation and Plasma Medical Sciences 2023; 7(7): 673 doi: 10.1109/TRPMS.2023.3272015
40
Anurima Patra, Hala Khasawneh, Garima Suman, Mark A. Nathan, Annie T. Packard, Geoffrey B. Johnson, Ajit H. Goenka. Atypical Metastases in the Abdomen and Pelvis From Biochemically Recurrent Prostate Cancer:11C-Choline PET/CT With Multimodality CorrelationAmerican Journal of Roentgenology 2022; 218(1): 141 doi: 10.2214/AJR.21.26426
41
Brandon A. Howard, Terence Z. Wong. 18F-FDG-PET/CT Imaging for Gastrointestinal MalignanciesRadiologic Clinics of North America 2021; 59(5): 737 doi: 10.1016/j.rcl.2021.06.001
42
Ashif Ahamed, Mahmadul Hasan, Arijit Samanta, Syed Sahajada Mahafujul Alam, Zarnain Jamil, Safdar Ali, Mehboob Hoque. Prospective pharmacological potential of cryptotanshinone in cancer therapyPharmacological Research - Modern Chinese Medicine 2023; 9: 100308 doi: 10.1016/j.prmcm.2023.100308
43
Qian Xue, Jianping Wu, Zehua Lei, Qing Wang, Weifeng Gao, Jinqiang Fu. Application value of fluorescence visualization-assisted technology in the resection of liver cancer: A systematic review and meta-analysisPhotodiagnosis and Photodynamic Therapy 2022; 39: 102940 doi: 10.1016/j.pdpdt.2022.102940
44
Preethi Guniganti, Andrea S. Kierans. PET/MRI of the hepatobiliary system: Review of techniques and applicationsClinical Imaging 2021; 71: 160 doi: 10.1016/j.clinimag.2020.10.056
45
Yi Luo, Lei Song, Xinyu Wang, Yujie Huang, Yongqiang Liu, Qi Wang, Ming Hong, Zhongyu Yuan. Uncovering the Mechanisms of Cryptotanshinone as a Therapeutic Agent Against Hepatocellular CarcinomaFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01264
46
Junya Mita, Takashi Maeda, Eiji Tsujita, Kyohei Yugawa, Shintaro Takaki, Keiji Tsuji, Naotaka Hashimoto, Ranma Fujikawa, Yuki Ono, Akihiro Sakai, Shinichi Tanaka, Rumi Matono, Takahiro Ohmine, Takuro Kometani, Shohei Yamaguchi, Kozo Konishi, Kenkichi Hashimoto. A case of difficult-to-diagnose hepatic reactive lymphoid hyperplasia finally diagnosed by using PCR analysis of IgH-gene rearrangements: a case reportInternational Cancer Conference Journal 2023; 13(1): 33 doi: 10.1007/s13691-023-00632-8
47
Abid Suddle, Helen Reeves, Richard Hubner, Aileen Marshall, Ian Rowe, Dina Tiniakos, Stefan Hubscher, Mark Callaway, Dinesh Sharma, Teik Choon See, Maria Hawkins, Suzanne Ford-Dunn, Sarah Selemani, Tim Meyer. British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adultsGut 2024; : gutjnl-2023-331695 doi: 10.1136/gutjnl-2023-331695
48
Tao Wang, Yinglei Deng, Sidan Wang, Jianfeng He, Shaobo Wang. Kinetic 18F-FDG PET/CT imaging of hepatocellular carcinoma: a dual input four-compartment modelEJNMMI Physics 2024; 11(1) doi: 10.1186/s40658-024-00619-1
49
Yushuang Qin, Siyuan Cheng, Yesen Li, Sijuan Zou, Minglong Chen, Dongling Zhu, Shi Gao, Hua Wu, Lei Zhu, Xiaohua Zhu. The development of a Glypican-3-specific binding peptide usingin vivoandin vitrotwo-step phage display screening for the PET imaging of hepatocellular carcinomaBiomaterials Science 2020; 8(20): 5656 doi: 10.1039/D0BM00943A
50
Joyce van Sluis, Ronald Borra, Charalampos Tsoumpas, Johannes H. van Snick, Mostafa Roya, Dik ten Hove, Adrienne H. Brouwers, Adriaan A. Lammertsma, Walter Noordzij, Rudi A.J.O. Dierckx, Riemer H.J.A. Slart, Andor W.J.M. Glaudemans. Extending the clinical capabilities of short- and long-lived positron-emitting radionuclides through high sensitivity PET/CTCancer Imaging 2022; 22(1) doi: 10.1186/s40644-022-00507-w
51
Yaoru Huang, Po-Yung Chen, Tzu-Yen Cheng, Jeng-Fong Chiou. Hepatic Reirradiation for Patients with Recurrent Hepatocellular CarcinomaApplied Sciences 2021; 11(4): 1598 doi: 10.3390/app11041598
52
Nozipho Nyakale, Luca Filippi, Colleen Aldous, Mike Sathekge. Update on PET Radiopharmaceuticals for Imaging Hepatocellular CarcinomaCancers 2023; 15(7): 1975 doi: 10.3390/cancers15071975